Disc Medicine, Inc.
IRON
40 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Sep 15 8:30 PM | Kevin BittermanDirector | Sale | 27,136 | $70.11 | $1.9M | 0(D) | View → |
| Sep 11, 2026 | Sep 11 8:11 PM | KEVIN J BITTERMAN | Proposed Sale | 27,136 | $70.11 | $1.9M | — | View → |
| Sep 4, 2026 | Sep 9 8:23 PM | Kevin BittermanDirector | Sale | 1,689 | $79.96 | $135.1K | 13,427(I) | View → |
| Sep 4, 2026 | Sep 4 8:36 PM | Atlas Venture Fund XII, LP | Proposed Sale | 18 | $79.37 | $1.4K | — | View → |
| Sep 4, 2026 | Sep 4 8:35 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 759 | $79.37 | $60.2K | — | View → |
| Sep 4, 2026 | Sep 4 8:34 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 912 | $79.37 | $72.4K | — | View → |
| Sep 4, 2026 | Sep 4 8:32 PM | Atlas Venture Fund X, LP | Proposed Sale | 2,212 | $79.37 | $175.6K | — | View → |
| Sep 3, 2026 | Sep 3 9:43 PM | Kevin BittermanDirector | Sale | 5,203 | $79.98 | $416.1K | 13,445(I) | View → |
| Sep 2, 2026 | Sep 3 9:43 PM | Kevin BittermanDirector | Sale | 49,164 | $80.17 | $3.9M | 13,499(I) | View → |
| Sep 1, 2026 | Sep 3 9:43 PM | Kevin BittermanDirector | Sale | 129 | $79.95 | $10.3K | 14,012(I) | View → |
| Sep 3, 2026 | Sep 3 9:09 PM | Atlas Venture Fund XII, LP | Proposed Sale | 54 | $80.05 | $4.3K | — | View → |
| Sep 3, 2026 | Sep 3 9:08 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 2,339 | $80.05 | $187.2K | — | View → |
| Sep 3, 2026 | Sep 3 9:08 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 2,810 | $80.05 | $224.9K | — | View → |
| Sep 3, 2026 | Sep 3 9:08 PM | Atlas Venture Fund X, LP | Proposed Sale | 6,822 | $80.05 | $546.1K | — | View → |
| Sep 2, 2026 | Sep 2 8:47 PM | Atlas Venture Fund XII, LP | Proposed Sale | 513 | $78.67 | $40.4K | — | View → |
| Sep 2, 2026 | Sep 2 8:46 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 22,099 | $78.67 | $1.7M | — | View → |
| Sep 2, 2026 | Sep 2 8:45 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 26,552 | $78.67 | $2.1M | — | View → |
| Sep 2, 2026 | Sep 2 8:44 PM | Atlas Venture Fund X, LP | Proposed Sale | 64,460 | $78.67 | $5.1M | — | View → |
| Aug 25, 2026 | Aug 27 12:10 AM | Jonathan Yen-Wen YuChief Operating Officer | Sale | 8,796 | $83.12 | $731.1K | 54,324(D) | View → |
| Aug 24, 2026 | Aug 27 12:10 AM | Jonathan Yen-Wen YuChief Operating Officer | Sale | 300 | $82.53 | $24.8K | 54,324(D) | View → |
Page 1 of 8
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 23 8:56 PM | Kevin BittermanDirector | Grant/Award | 6,212 | $70.79 | 6,212(D) | View → |
| Jun 18, 2026 | Jun 23 8:54 PM | Nadim AhmedDirector | Grant/Award | 5,176 | $70.79 | 5,176(D) | View → |
| Jun 16, 2026 | Jun 18 8:43 PM | Jonathan Yen-Wen YuChief Operating Officer | Option Exercise | 18,612 | $9.86 | 31,951(D) | View → |
| Feb 10, 2026 | Feb 12 12:50 AM | Rahul KharaChief Legal Officer | Grant/Award | 25,500 | $74.75 | 25,500(D) | View → |
| Feb 10, 2026 | Feb 12 12:46 AM | Pamela StephensonChief Commercial Officer | Grant/Award | 25,500 | $74.75 | 25,500(D) | View → |
| Feb 10, 2026 | Feb 12 12:40 AM | William Jacob SavageChief Medical Officer | Grant/Award | 25,500 | $74.75 | 25,500(D) | View → |
| Feb 10, 2026 | Feb 12 12:34 AM | Jonathan Yen-Wen YuChief Operating Officer | Grant/Award | 25,500 | $74.75 | 25,500(D) | View → |
| Feb 10, 2026 | Feb 12 12:26 AM | Jean M. FranchiChief Financial Officer | Grant/Award | 25,500 | $74.75 | 25,500(D) | View → |
| Feb 10, 2026 | Feb 12 12:12 AM | John D QuiselDirector, Chief Executive Officer | Grant/Award | 82,800 | $74.75 | 82,800(D) | View → |
| Jan 20, 2026 | Jan 21 11:55 PM | Rahul KharaChief Legal Officer | Option Exercise | 1,000 | $13.50 | 21,270(D) | View → |
← Previous
Page 2 of 2